v3.26.1
Stock-based Compensation - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 21, 2026
Feb. 21, 2025
Jan. 03, 2025
Feb. 28, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jan. 26, 2026
Jan. 01, 2026
Dec. 31, 2025
Jun. 07, 2024
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Percentage of Common Stock Outstanding, During Period Increase (Decrease)     4.00%       4.00%          
Common stock shares reserved for issuance     27,453,993   3,350,850   3,350,850       5,197,330  
Stock-based compensation expense         $ 5,346,010 $ 4,208,742 $ 10,905,776 $ 6,250,938        
CorHepta Pharmaceuticals [Member]                        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Number of stock options granted   2,489,030                    
Restricted Stock [Member]                        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Number of Shares, Forfeited 664,089                      
Restricted Stock [Member] | CorHepta Pharmaceuticals [Member]                        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Stock-based compensation expense         0 $ 700,000 400,000 $ 1,000,000        
Restricted share issued       1,660,222                
Service based vesting shares       996,133                
Fair Value Of Restricted Stock Granted             4,900,000          
Unrecognized Compensation Cost         $ 0   $ 0          
Employee stock plan                        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Number of stock options granted             13,539,142 25,756,010        
Stock option, strike price         $ 1.99 $ 2.42 $ 1.99 $ 2.42        
Stock option, aggregate grant date fair value           $ 53,200,000   $ 53,200,000        
Performance-based options, Granted               2,056,049        
Performance-based options, weighted average strike price               $ 2.35        
Employee stock plan | Employee Stock Option                        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Stock option, aggregate grant date fair value         $ 21,500,000   $ 21,500,000          
Two Thousand And Twenty Plan [Member]                        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                        
Plan modification             41,386,723          
Common stock shares reserved for issuance     27,453,993           3,000,000 6,969,206   2,500,000